Edesa Biotech Stock Alpha and Beta Analysis
| EDSA Stock | USD 1.51 0.03 1.95% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Edesa Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Edesa Biotech over a specified time horizon. Remember, high Edesa Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Edesa Biotech's market risk premium analysis include:
Beta 0.82 | Alpha (0.94) | Risk 4.69 | Sharpe Ratio (0.16) | Expected Return (0.74) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Edesa Biotech Backtesting, Edesa Biotech Valuation, Edesa Biotech Correlation, Edesa Biotech Hype Analysis, Edesa Biotech Volatility, Edesa Biotech History and analyze Edesa Biotech Performance. Edesa Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Edesa Biotech market risk premium is the additional return an investor will receive from holding Edesa Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Edesa Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Edesa Biotech's performance over market.| α | -0.94 | β | 0.82 |
Edesa Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Edesa Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Edesa Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Edesa Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Edesa Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edesa Biotech shares will generate the highest return on investment. By understating and applying Edesa Biotech stock market price indicators, traders can identify Edesa Biotech position entry and exit signals to maximize returns.
Edesa Biotech Return and Market Media
The median price of Edesa Biotech for the period between Sat, Oct 11, 2025 and Fri, Jan 9, 2026 is 1.74 with a coefficient of variation of 23.22. The daily time series for the period is distributed with a sample standard deviation of 0.44, arithmetic mean of 1.89, and mean deviation of 0.36. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Is Edesa Biotech Inc. still worth holding after the dip - Weekly Stock Summary Smart Money Movement Alerts - newser.com | 10/24/2025 |
2 | Favourable Signals For Edesa Biotech Numerous Insiders Acquired Stock | 10/28/2025 |
3 | EDSA EB05 Reduces Risk of Death 25 percent in Phase 3 ARDS Trial | 11/05/2025 |
4 | Is Edesa Biotech Inc. stock affected by interest rate hikes - Trade Signal Summary Daily Momentum Trading Reports - newser.com | 11/13/2025 |
5 | Will Edesa Biotech Inc. stock deliver better than expected guidance - newser.com | 11/17/2025 |
6 | Acquisition by Nijhawan Pardeep of 8766 shares of Edesa Biotech subject to Rule 16b-3 | 12/01/2025 |
7 | EDSA Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026 | 12/15/2025 |
8 | Acquisition by Nijhawan Pardeep of 10444 shares of Edesa Biotech subject to Rule 16b-3 | 01/05/2026 |
About Edesa Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Edesa or other stocks. Alpha measures the amount that position in Edesa Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Days Sales Outstanding | 63.81 | 92.27 | PTB Ratio | 126.03 | 132.34 |
Edesa Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Edesa Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Edesa Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Edesa Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Edesa Biotech. Please utilize our Beneish M Score to check the likelihood of Edesa Biotech's management manipulating its earnings.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Build Portfolio with Edesa Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Edesa Biotech Backtesting, Edesa Biotech Valuation, Edesa Biotech Correlation, Edesa Biotech Hype Analysis, Edesa Biotech Volatility, Edesa Biotech History and analyze Edesa Biotech Performance. For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Edesa Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.